Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Japanese pharmaceutical company Eisai said it was building a £75 million research and manufacturing centre in Hertfordshire which would create 500 jobs. Eisai, one of the world's top 20 pharmaceutical companies, already has a research and development facility at University College London. But the new Hatfield plant will be the first time a Japanese pharmaceutical company has opened a manufacturing facility in the UK.
Trade minister Ian Pearson said the Amgen and Eisai decisions in January 2006 demonstrated Britain's attractiveness as a location for pharmaceutical and biotech companies. 'These two significant investments reinforce the UK's position as having the largest biotech sector in Europe. Both the Amgen and Eisai investments show that our research and development capability is truly world class.'
Eurofound (2006), Eisai, Business expansion in United Kingdom, factsheet number 62822, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/62822.